Zelinska, N.,
Skorodokb, J.,
Malievsky, O.,
Rosenfeldd, Ron G.,
Zadike, Zvi,
Korenf, R.,
Vanderf, Sh.,
Hartf, G.,
Radziukg, K. (2016) -weekly subcutaneous (SC) administration of MOD-4023 were
assessed in children with GHD over a period of 24 months
of the response to
MTX. No unequivocal predictive SNP has been found yet, because many were
assessed in only one
Galimov, Dmitriy,
Galimov, Oleg,
Khanov, Vladislav,
Sufiyarov, Rinat,
Ibragimov, Tel'man,
Vagizova, Gul'naz (2023) prosthetic hernioplasty. In this groups was
assessed the quality of life by SF-36 questionnaire before and 1